Study of ALK-001 on the Progression of Stargardt Disease

Clinical trial NCT07419334 · RECRUITING

Trial details

NCT number: NCT07419334
Sponsor: Alkeus Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stargardt Disease

Start date: 2026-06-01
Primary completion: 2029-10-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.